(function(){var loadHandler=window['sl_{72C0429F-FC8A-44E7-B152-D6826999A52C}'];loadHandler&&loadHandler(120, '<div id="spr0_42c1b19b"><div id="spr1_42c1b19b" class="kern slide"><img id="img0_42c1b19b" src="data/img2.png" width="720px" height="540px" alt="" style="left:0px;top:0px;"/></div><div id="spr2_42c1b19b" class="kern slide"><div id="spr3_42c1b19b" style="top:3.651px;"><div style="width:0px;"><span id="txt0_42c1b19b" data-width="197.630859" style="left:111.314px;top:-0.954px;">Example Task</span></div></div><div id="spr4_42c1b19b" style="left:30.545px;top:78.039px;"><div style="width:0px;"><span id="txt1_42c1b19b" data-width="618.169922" style="left:7.2px;top:1.323px;">A woman of 68 years old noted a lump in the left breast about a month ago; she was</span></div><div style="width:0px;"><span id="txt2_42c1b19b" data-width="628.760742" style="left:7.2px;top:22.923px;">referred to the breast cancer clinic, where she was diagnosed with breast cancer.  The</span></div><div style="width:0px;"><span id="txt3_42c1b19b" data-width="640.995117" style="left:7.2px;top:44.523px;">tumour is 6 cm size with enlarged elastic mobile axillary lymph nodes.  Chest X-ray, liver</span></div><div style="width:0px;"><span id="txt4_42c1b19b" data-width="635.686523" style="left:7.2px;top:66.123px;">ultrasound and liver function tests (LFT’s) do not show signs of distant spread.  Tumour</span></div><div style="width:0px;"><span id="txt5_42c1b19b" data-width="621.439453" style="left:7.2px;top:87.723px;">biopsy confirmed invasive ductal carcinoma.  Molecular markers show that tumour is</span></div><div style="width:0px;"><span id="txt6_42c1b19b" data-width="635.756836" style="left:7.2px;top:109.323px;">oestrogen receptor positive, progesterone receptor positive, HER2 negative.  No family</span></div><div style="width:0px;"><span id="txt7_42c1b19b" data-width="643.983398" style="left:7.2px;top:130.923px;">history of breast cancer.  Concomitant conditions include acute MI 5 years ago &amp; history</span></div><div style="width:0px;"><span id="txt8_42c1b19b" data-width="527.581055" style="left:7.2px;top:152.523px;">of deep vein thrombosis; general condition is good for the patient’s age.</span></div><div style="width:0px;"><span id="txt9_42c1b19b" data-width="625.086914" style="left:7.2px;top:195.723px;">Present case summary to the class.  Compare the treatments below; suggest which of</span></div><div style="width:0px;"><span id="txt10_42c1b19b" data-width="329.273438" style="left:7.2px;top:217.323px;">them may be suitable and which is not, why?</span></div><div style="width:0px;"><span id="txt11_42c1b19b" data-width="647.173828" style="left:7.2px;top:260.523px;">1. Immediate mastectomy; after surgery: radiotherapy, adjuvant Tamoxifen for 5 years +</span></div><div style="width:0px;"><span id="txt12_42c1b19b" data-width="146.680664" style="left:7.2px;top:282.123px;">Herceptin for 1 year</span></div><div style="width:0px;"><span id="txt13_42c1b19b" data-width="628.189453" style="left:7.2px;top:315.723px;">2. Neo-adjuvant Letrozole for 3 months, reassessment after 3 months to decide about</span></div><div style="width:0px;"><span id="txt14_42c1b19b" data-width="119.794922" style="left:7.2px;top:337.323px;">the surgery type</span></div><div style="width:0px;"><span id="txt15_42c1b19b" data-width="639.254883" style="left:7.2px;top:370.923px;">3. Neo-adjuvant Fazlodex for 3 months followed by mastectomy &amp; radiotherapy, then 5</span></div><div style="width:0px;"><span id="txt16_42c1b19b" data-width="194.150391" style="left:7.2px;top:392.523px;">years of adjuvant Fazlodex</span></div><div style="width:0px;"><span id="txt17_42c1b19b" data-width="482.422852" style="left:7.2px;top:426.123px;">Suggest what might be missed in the assessment and treatments?</span></div></div></div></div>');})();